Migration, psychosis and immune activation - Migration, psychosis and immune activation

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 60 人开始时间: 待定最近更新: 2024年5月6日

适应症

试验速览

暂无简介。

•Group 1. 15 participants, born in or born from parents born in Morocco, Turkey, Surinam or the Netherlands Antilles, age at migration < 5 years for first generation immigrants, current age 18-40, diagnosis of DSM IV schizophrenia, schizoaffective disorder or schizophreniform disorder, use of antipsychotic medication for less than two years.
•Group 2. Contrast patients: 15 participants, born in the Netherlands and both parents born in the Netherlands, other inclusion criteria as in group 1.;Controls:
•Exposed controls: 15 participants, born in or born from parents born in Morocco, Turkey, Surinam or the Netherlands Antilles, age at migration < 5 years for first generation immigrants, current age 18-40, no history of psychotic disorder. Unexposed controls: 15 participants, born in the Netherlands and both parents born in the Netherlands, age 18-40, no history of psychotic disorder.

•Diagnosis of DSM IV substance induced psychotic disorder, mood disorder with psychotic features, delusional disorder, psychotic disorder NOS or psychotic disorder due to a somatic condition; IQ lower than 70.;Controls:
•History of psychotic disorder; IQ lower than 70.

发起方